Intellex Acquires Expert by Big Village

We're thrilled to announce that Intellex has acquired Expert by Big Village, effective March 22, 2024. This strategic move enhances our capabilities and strengthens our commitment to delivering exceptional solutions to our customers.

Stay tuned for more updates on how this acquisition will benefit our clients and experts.

For inquiries or more information, please contact us at info@intellex.com.

×

Find an Expert

ID: 726001 Netherlands

Regulatory Affairs and Pricing and Reimbursement-European and Emerging Market

She has advised many International clients with regards to requirements for dossiers as well as routemap for ANDA Procedure in addition to the requirements for DMF dossier as well as routemap for EDQM Certificate of Suitability Procedure. She has worked…

ID: 725921 Ireland

Biopharmaceutical Processes

Expert has a BSc. in biotechnology from London (Imperial College) & a Ph.D in cell physiology from Liverpool (UK). Expert has over 20 years experience gained in a wide range of companies in the pharmaceutical and biopharmaceutical fields. He has…

ID: 725858 India

Regulatory Affairs, Technology Management, Pharmaceutical Industry, Turnaround Management

Expert has experience in applying 21 CFR Part 11 to the manufacturing of pharmaceuticals and preparing and facing FDA inspections. He has more than 20 years of experience in various facets of API industry ranging from research to manufacturing, projects,…

ID: 725712 Pennsylvania, USA

Pharmaceutical Process Research, Development, and Manufacturing

Expert has 17 years experience of research, development and manufacturing of APIs. Expert has three patents from research, development and manufacturing of etoposide and etoposide phosphate. He also has extensive experience with platinum anticancer drugs, including cisplatin, carboplatin, and oxaliplatin.…

ID: 725690 New Jersey, USA

Industrial Mineral FiIlers, Coupling Agents, Silanes, and Treatment Technology, Nano Metalic Oxides

Expert is presently consulting for Gelest Corporation working to promote next generation silane chemistry as well as developing new business for their State Of The Art mineral treatment facility. Nanophase Technologies developinging next generation, out of the ordinary usage of…

ID: 725402 Ohio, USA

Specialty and Fine Chemicals, Pharmaceuticals, Resins, Coatings

He has worked in the process development, manufacturing related to the technologies, chemistries. He has also worked in intellectual property strategy, commercialization of many different technologies. He is able to do this as he has cross- fertilized manufacturing and processes…

ID: 725176 California, USA

Nanobiotechnology, Drug Delivery Platforms, Medical Devices, Targeted Therapeutics, Diagnostics

Expert has extensive experience establishing R&D operations in early stage biotechnology companies. He applied his knowledge in nano(bio)technology to develop innovative solutions to drug delivery and drug targeting challenges. His efforts to enhance the use of biomaterials in a variety…

ID: 725173 Germany

Cleanrooms, Contamination Control, Ultrapure Media, Qualification and Validation, GMP, AMC

Expert has been active in aersol physics for more than 25 years. His PhD covers also the areas of environmental, indoor and cleanroom aerosols. He worked in a variety of scientific and technical projects covering the health effects of particles…

ID: 725163 Florida, USA

Medical Device Regulatory Support, Medical Device Registration, etc.

Expert is a Regulatory and Quality Consultant with strong team building skills for high technology corporations. A hands-on career of increasing leadership positions with a broad range of responsibilities in manufacturing, regulatory affairs and new product introductions. A committed professional…

ID: 725075 Minnesota, USA

Orphan Drugs: FDA/EU/Canada; FDA Approval; Drug Development: CMC, QA, QC, Manufacturing

12 product approvals from FDA including 6 new chemical entities, a 510k device, and three major pharmaceutical efficacy indication supplemental approvals. All received 5-10 years of regulatory exclusivity (Hatch-Waxman, Orphan Drug). These products are generating over $100 million dollars in…

Dev Tool:

Request: experts/active-pharmaceutical-ingredient/page/7
Matched Rewrite Rule: ^experts\/([^\/]*)\/?([^\/]*)\/?page\/([0-9]{1,})\/?
Matched Rewrite Query: pagename=experts&searchKeyword=active-pharmaceutical-ingredient&searchDiscipline=&paged=7
Loaded Template: page-experts.php